Express Pharma
Home  »  Latest Updates  »  Natco Pharma receives EIR from US FDA

Natco Pharma receives EIR from US FDA


The inspection was conducted at Natco Pharma’s Kothur facility in Telangana

Drug firm Natco Pharma has received establishment inspection report (EIR) from the US health regulator for its Kothur facility in Telangana after successful completion of inspection.

Natco Pharma announces successful EIR from the US Food and Drug Administration (US FDA) for the inspection conducted at its drug manufacturing facility in Kothur village in Mahabubnagar district during January 16-24, 2017, the company said in a BSE filing today.

“The Kothur facility predominantly caters to regulated international markets, including the US,” it added.

EIR is given to an establishment after completion of inspection by the US FDA.

Comments are closed.